2022 annual financial data
iBio 2022 Operating margin
iBio 2022 operating margin with verified reported values.
Direct answer
Operating margin was -1,576.27%.
Operating income was -29,697,000 USD and net income was -50,391,000 USD.
Operating cash flow was -37,802,000 USD.
Get free iBio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,884,000 USD
- Operating income
- -29,697,000 USD
- Net income
- -50,391,000 USD
- Operating cash flow
- -37,802,000 USD